Search

everythinglearnresearchcommunity

for

Search:↓

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

A blood pressure drug, diltiazem, may also help treat influenza.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Some nutraceuticals may help in COVID-19 prevention and treatment, but more research is needed.

Mice studies show that Protein Phosphatase 2A is crucial for cell growth, development, and disease prevention.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

A substance called poly(I:C) increases a protein called carbonic anhydrase II in skin cells, which might help with skin defense and healing.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Dengue virus can infect human hair follicle cells and may cause hair loss.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

CO2 laser treatment for aging skin significantly changes immune system-related genes.

TLR4 is important in aging-related diseases and could be a new treatment target.

Antigen presenting cells around hair follicles are crucial in SLE-related hair loss.

Sugars from Sargassum and brown algae may have health benefits like fighting viruses and helping with wound healing, but there are challenges in using them.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Chicken feather gene mutation helps understand human hair disorders.

RNAi-based biopesticides could be safe and effective for pest control with careful development and risk assessment.